Market Overview:
The global soft tissue allograft market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising demand for organ transplants, and technological advancements in the field of regenerative medicine. The orthopedic segment is expected to account for the largest share of the global soft tissue allograft market in 2018. This segment is driven by factors such as growing geriatric population and increasing prevalence of chronic diseases such as arthritis and osteoporosis. The hospitals segment is expected to account for the largest share of the global soft tissue allograft market in 2018. This can be attributed to factors such as rising number of surgical procedures, increase in awareness about benefits offered by soft tissue allografts, and growing number of private hospitals across regions.
Product Definition:
A soft tissue allograft is a piece of donated tissue used to replace or repair injured or damaged soft tissues, such as muscles, tendons and ligaments. Soft tissue allografts can be harvested from a variety of sources, including cadavers and live donors. They are often used to promote healing in difficult-to-heal wounds or injuries.
Orthopedic:
Orthopedic is a branch of medicine that deals with the prevention and treatment of injuries caused to bones, ligaments, cartilage & muscles. It also provides care for diseases associated with joints such as osteoarthritis. The orthopedic industry has been witnessing lucrative growth over the past few years owing to increasing geriatric population base coupled with rising incidences of sports-related injuries across the globe.
Dentistry:
Dentistry is the branch of medicine that is concerned with prevention, diagnosis, and treatment of diseases related to oral hygiene and dental aesthetics. The scope of dentistry also includes surgery for problems such as tooth decay or cavity, tooth loss due to trauma or disease and other disorders pertaining to facial structure.
Soft tissue allografts are used by dentists for various reasons such as filling in missing teeth & bonding fractures & repairing damaged teeth.
Application Insights:
The hospitals segment dominated the global soft tissue allograft market in 2017. Hospitals are the most preferred locations for Surgical Reconstruction of Soft Tissue Defects and this procedure is performed by a multidisciplinary team of surgeons, anesthesiologists, and registered nurses. The surgical procedures involving allografts are considered as minimal invasive surgeries with high success rates as compared to other conventional surgeries.
Orthopedic clinics were the second largest application segment in 2017 owing to rising number of patients seeking treatment for hip & joint pain after surgery or trauma injuries at these clinics. These clinics focus on providing personalized care based on each patient¢â‚¬â„¢s needs by gathering information regarding medical history, current health conditions & past medical history before offering any surgical/non-surgical treatments or prescriptions related to joints & bones or muscles&tendon problems at these centers.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing number of road accidents, sports injuries, and chronic diseases. In addition, rising adoption of advanced surgical procedures is expected to drive the regional demand for soft tissue grafts. The U.S., which accounted for a major share in North America market due to high healthcare expenditure and availability of skilled professionals is anticipated to be a key revenue generator over the forecast period.
Asia Pacific region is projected to witness lucrative growth during the forecast period owing its developing economy and increasing patient awareness about available alternatives such as composite grafts or allografts for soft tissue reconstruction surgeries.
Europe also held a considerable share in global revenue generation due to presence of developed economies such as Germany.
Growth Factors:
- Increasing incidence of chronic diseases: The increasing incidence of chronic diseases such as cancer, orthopedic disorders, and cardiovascular diseases is expected to drive the demand for soft tissue allografts in the coming years.
- Growing awareness about benefits of soft tissue allografts: There is a growing awareness among patients and healthcare professionals about the benefits of using soft tissue allografts for various surgical procedures. This is likely to boost the demand for these products in the near future.
- Technological advancements in soft tissue allograft manufacturing: The manufacturers are focusing on developing technologically advanced products that can offer better outcomes to patients undergoing surgery. This is likely to fuel the growth of the Soft Tissue Allograft market in upcoming years.
- Rising number of surgeries requiring use of soft tissue allografts: The number of surgeries requiring usesoft tissueallgosftsis increasing at a rapid pace due to rising prevalenceof various chronicdiseasesworldwideThegrowing demandfortheseproductsisexpectedtoreflectintherisingmarketgrowthinthecomingyears5
Scope Of The Report
Report Attributes
Report Details
Report Title
Soft Tissue Allograft Market Research Report
By Type
Orthopedic, Dentistry, Wound Care, Others
By Application
Hospitals, Orthopedic Clinics, Dental Clinics, Others
By Companies
Zimmer Biomet, MiMedix Group, Allergan, AlloSource, CONMED Corporation, RTI Surgical, Lattice Biologics, B. Braun Melsungen AG, AlonSource Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Soft Tissue Allograft Market Report Segments:
The global Soft Tissue Allograft market is segmented on the basis of:
Types
Orthopedic, Dentistry, Wound Care, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Orthopedic Clinics, Dental Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zimmer Biomet
- MiMedix Group
- Allergan
- AlloSource
- CONMED Corporation
- RTI Surgical
- Lattice Biologics
- B. Braun Melsungen AG
- AlonSource Group
Highlights of The Soft Tissue Allograft Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Orthopedic
- Dentistry
- Wound Care
- Others
- By Application:
- Hospitals
- Orthopedic Clinics
- Dental Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Soft Tissue Allograft Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Soft tissue allograft is a type of transplant where healthy donor tissue is used to replace damaged or diseased tissue in the body. This procedure can be used to treat a wide variety of conditions, including injuries and diseases of the skin, muscles, and bones.
Some of the major players in the soft tissue allograft market are Zimmer Biomet, MiMedix Group, Allergan, AlloSource, CONMED Corporation, RTI Surgical, Lattice Biologics, B. Braun Melsungen AG, AlonSource Group.
The soft tissue allograft market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Soft Tissue Allograft Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Soft Tissue Allograft Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Soft Tissue Allograft Market - Supply Chain
4.5. Global Soft Tissue Allograft Market Forecast
4.5.1. Soft Tissue Allograft Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Soft Tissue Allograft Market Size (000 Units) and Y-o-Y Growth
4.5.3. Soft Tissue Allograft Market Absolute $ Opportunity
5. Global Soft Tissue Allograft Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Soft Tissue Allograft Market Size and Volume Forecast by Type
5.3.1. Orthopedic
5.3.2. Dentistry
5.3.3. Wound Care
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Soft Tissue Allograft Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Soft Tissue Allograft Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Orthopedic Clinics
6.3.3. Dental Clinics
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Soft Tissue Allograft Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Soft Tissue Allograft Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Soft Tissue Allograft Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Soft Tissue Allograft Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Soft Tissue Allograft Demand Share Forecast, 2019-2026
9. North America Soft Tissue Allograft Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Soft Tissue Allograft Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Soft Tissue Allograft Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Orthopedic Clinics
9.4.3. Dental Clinics
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Soft Tissue Allograft Market Size and Volume Forecast by Type
9.7.1. Orthopedic
9.7.2. Dentistry
9.7.3. Wound Care
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Soft Tissue Allograft Demand Share Forecast, 2019-2026
10. Latin America Soft Tissue Allograft Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Soft Tissue Allograft Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Soft Tissue Allograft Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Dental Clinics
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Soft Tissue Allograft Market Size and Volume Forecast by Type
10.7.1. Orthopedic
10.7.2. Dentistry
10.7.3. Wound Care
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Soft Tissue Allograft Demand Share Forecast, 2019-2026
11. Europe Soft Tissue Allograft Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Soft Tissue Allograft Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Soft Tissue Allograft Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Dental Clinics
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Soft Tissue Allograft Market Size and Volume Forecast by Type
11.7.1. Orthopedic
11.7.2. Dentistry
11.7.3. Wound Care
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Soft Tissue Allograft Demand Share, 2019-2026
12. Asia Pacific Soft Tissue Allograft Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Soft Tissue Allograft Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Soft Tissue Allograft Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Dental Clinics
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Soft Tissue Allograft Market Size and Volume Forecast by Type
12.7.1. Orthopedic
12.7.2. Dentistry
12.7.3. Wound Care
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Soft Tissue Allograft Demand Share, 2019-2026
13. Middle East & Africa Soft Tissue Allograft Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Soft Tissue Allograft Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Soft Tissue Allograft Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Dental Clinics
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Soft Tissue Allograft Market Size and Volume Forecast by Type
13.7.1. Orthopedic
13.7.2. Dentistry
13.7.3. Wound Care
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Soft Tissue Allograft Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Soft Tissue Allograft Market: Market Share Analysis
14.2. Soft Tissue Allograft Distributors and Customers
14.3. Soft Tissue Allograft Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zimmer Biomet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MiMedix Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Allergan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AlloSource
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CONMED Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. RTI Surgical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lattice Biologics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. B. Braun Melsungen AG
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. AlonSource Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
